Therapeutic approaches to Alzheimer's disease

Current Opinion in Chemical Biology

Volumn 4, Issue 4, 2000, Pages 377-382

  Thorsett, Eugene D ^a   Latimer, Lee H ^a  

^a ELAN PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE INHIBITOR; BETA SECRETASE; BRAIN PEPTIDE; GAMMA SECRETASE; KETONE DERIVATIVE; PEPSTATIN; PRESENILIN 1; PROTEIN PRECURSOR; PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR; SIB 1281; SIB 1405; STAT5 PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYLOID NEUROPATHY; DISEASE MODEL; DRUG INHIBITION; DRUG MECHANISM; HUMAN; IMMUNIZATION; NONHUMAN; PROTEIN AGGREGATION; REVIEW; STRUCTURE ANALYSIS; TRANSGENIC MOUSE;

EID: 0033860546     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(00)00102-2     Document Type: Review

References (36)

1. The molecular pathology of Alzheimer's disease
2. Amyloid, the presenillins and Alzheimer's disease
3. Visualization of Aβ42(43) and Aβ40 in senile plaques with end specific Ab monoclonals: Evidence that an initially deposited species is Aβ42(43)
4. Aβ-42 deposition precedes other changes in PS-1 Alzheimer's disease
5. Regulation of amyloid precursor protein cleavage
6. The gene defects responsible for familial Alzheimer's disease
7. New insights into the genetics of Alzheimer's disease
8. Mutation of the β-amyloid precursor protein infamilial Alzheimer's disease increases β-protein production
9. Secreted amyloid β-protein similar to that in senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
10. An increased percentage of long amyloid β-protein secreted by familial amyloid β-protein precursor (β APP 717) mutants
11. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice
12. Enhancement of amyloid β-42 secretion by 28 different presenillin 1 mutations of familial Alzheimer's disease
13. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
14. Amyloid precursor protein processing and A β42 deposition in transgenic mouse model of Alzheimer's disease
15. Cleavage of Alzheimer's amyloid precursor protein by α-secretase occurs at the surface of neuronal cells
16. β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE
17. Identification of a novel aspartic protease (asp2) as β-secretase
18. Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity
19. Purification and cloning of amyloid precursor protein β-secretase from human brain
20. Modulation of amyloid β-protein precursor processing as a means of retarding progression of Alzheimer's disease
21. Presenillins: Molecular switches between proteolysis and signal transduction
22. The presenilins in Alzheimer's disease - Proteolysis holds the key
23. Two transmembrane aspartates in presenillin-1 required for presenilin endoproteolysis and γ-secretase activity
24. Signal transduction by activated m-notch: Importance of proteolytic processing and its regulation by the extracellular domain
25. Peptidomimetic probes and molecular modeling suggest that Alzheimer's γ-secretase is an intramembrane-cleaving aspartyl protease
26. A combinatorial approach to the identification of dipeptide aldehyde inhibitors of β-amyloid production
27. The amyloid hypothesis in Alzheimer's disease: Progress to date
28. Rank-order of potencies for inhibition of the secretion of Aβ40 and Aβ42 suggests that both are generated by a single γ-secretase
29. Alzheimer's disease: Correlation of the suppression of β-amyloid peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasome
30. Inhibition of amyloid β-protein production in neural cells by the serine protease inhibitor AEBSF
31. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-β precursor protein and amyloidogenic Aβ peptide formation
32. Immunization with amyloid-β attenuates Alzheimer disease-like pathology in the PDAPP mouse
33. Recognition sequence design for peptidyl modulators of β-amyloid aggregation and toxicity
34. Modified-peptide inhibitors of amyloid β-peptide polymerization
35. Controlling polymerization of β-amyloid and prion-derived peptides with synthetic small molecule ligands
36. A short synthesis of the β-amyloid aggregation inhibitor 3-p-toluoyl-2-[4'-(3-diethylaminpropoxy)-phenyl]-benzofuran